From genomic epidemiology of infectious agents, to evolutionary genomics of pathogens, we are host to world renowned microbial genomics.
Aims of the research
The IMI is host to world renowned microbial genomics research. From the creation of the MicrobesNG sequencing provider, to playing a pivotal role in the creation of the CLIMB infrastructure for microbial genomic analysis, the IMI has been at the very forefront of academic microbial genomics research in the UK. Our work ranges from genomic epidemiology of infectious agents, to evolutionary genomics of pathogens, and in field detection of outbreak agents using portable genome sequencing technology. IMI also has a significant profile in metagenomics and microbiome research.
Our work ranges from studying the human gut and respiratory microbiome to studying the dissemination of antimicrobial resistance in the environment. IMI is also a key partner in the Microbiome Treatment Centre at QE Hospital, the first clinically accredited provider of faecal microbiome transplants in the UK, and the cornerstone of research projects on topics such as FMT clearance of C. difficile and colitis. Our work is funded by MRC, BBSRC, Wellcome, Royal Society, and industry, with academic and clinical collaborations making our microbial genomics research some of the best in the world.